title: Sialadenosis in bulimia. A new treatment.
abstract: OBJECTIVE
  To see whether a cholinomimetic medication would help resolve the parotid gland enlargement associated with self-induced vomiting in bulimic patients.
  
  
  METHODS
  The medication was administered on an inpatient eating disorder unit to bulimic patients with refractory sialadenosis.
  
  
  METHODS
  Pilocarpine hydrochloride drops were administered orally at a dosage of 1.25 to 5.0 mg/d until the parotid gland enlargement was significantly reduced.
  
  
  RESULTS
  There was a marked diminution in the size of the parotid gland enlargement.
  
  
  CONCLUSIONS
  Pilocarpine has proved to be beneficial in the treatment of sialadenosis in bulimic patients.
authors.affiliation: Department of Internal Medicine, Columbine Hospital, Littleton, CO 80126.
authors.forename: P S
authors.initials: PS
authors.lastname: Mehler
authors.forename: J A
authors.initials: JA
authors.lastname: Wallace
mesh_terms: D000328:Adult; D002032:Bulimia / Q000150:complications*; D005260:Female; D006801:Humans; D006984:Hypertrophy; D010305:Parotid Diseases / Q000188:drug therapy* / Q000209:etiology*; D010862:Pilocarpine / Q000627:therapeutic use
chemical_list: D010862:Pilocarpine